Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

marketwatch.com - Fuji Pharma 1H Net Y713.00M Vs Net Y1.29B
Fuji Pharma 1H Net Y713.00M Vs Net Y1.29B
MarketWatch

Fuji Pharma Co. Ltd. (4554.TO) Japan Half-Year Ended March 31 GROUP 2026 2025 Revenue Y29.72 bln Y24.10 bln Operating Profit Y4.40 bln Y2.31 bln Pretax Profit Y4.26 bln Y2.21 bln Net Profit Y713.00 mln Y1.29 bln Per share Earnings Y28.75 Y52.83…

washingtonexaminer.com - James Capretta - The Trump-Pharma deals reflect the flaws of state capitalism
The Trump-Pharma deals reflect the flaws of state capitalism
Washington Examiner

Beginning in 2017, President Donald Trump has sought to implement a policy affecting drug prices now known as the “most favored nation” approach, a term borrowed from international trade agreements. The intention is to bar biopharma…

ciol.com - Deepali Jain - Startup SwishX Launches Agentic AI Platform for Pharma, Raises $2.2 Million Seed Funding
Startup SwishX Launches Agentic AI Platform for Pharma, Raises $2.2 Million Seed Funding
CIOL

Bengaluru-based startup SwishX has launched what it called the world's first Agentic AI platform built exclusively for pharmaceutical and medtech companies, as healthcare and life sciences firms increasingly turn to artificial intelligence (AI) to…

cnbc.com - Sawdah Bhaimiya - Hantavirus cases spark surge in pharma and biotech stocks - here's why
Hantavirus cases spark surge in pharma and biotech stocks - here's why
CNBC

Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak. Moderna, Inovio, Novavax, and Emergent Biosolutions rose in early market trading. 'With regards to current headlines, we see no meaningful revenue…

statnews.com - Andrew Joseph - Bristol Myers Squibb partners with China's Hengrui Pharma on a dozen drugs
Bristol Myers Squibb partners with China's Hengrui Pharma on a dozen drugs
STAT

Bristol Myers Squibb announced on Tuesday a partnership with Hengrui Pharma covering more than a dozen early-stage programs, the latest and a notably large case of a global pharmaceutical company looking to China for its next medicines. The…

247wallst.com - Trey Thoelcke - Pfizer vs Eli Lilly: Different Bets on Pharma M&A
Pfizer vs Eli Lilly: Different Bets on Pharma M&A
24/7 Wall St

Eli Lilly (LLY) has shown revenue growth from a position of strength while Pfizer (PFE) is still rebuilding from the COVID cliff. For a retirement-focused investor, one may be more temping now but the other may be the stronger long-term franchise.

thehindubusinessline.com - Torrent Pharma says JB Chemicals merger in final phase, expects completion in 1-2 months
Torrent Pharma says JB Chemicals merger in final phase, expects completion in 1-2 months
BusinessLine

Torrent Pharmaceuticals said the merger process of Mumbai-based JB Chemicals & Pharmaceuticals Ltd with the company has entered its final stage, with a hearing scheduled in the second week of June and the transaction expected to become effective…

benzinga.com - Sweta Killa - Bristol Myers Squibb Strikes $15.2 Billion Drug Development Deal With Hengrui Pharma - Bristol-Myers Squi
Bristol Myers Squibb Strikes $15.2 Billion Drug Development Deal With Hengrui Pharma - Bristol-Myers Squi
Benzinga

Bristol-Myers Squibb Co. (NYSE:) on Tuesday announced a partnership with Hengrui Pharma to develop a portfolio of 13 early-stage programs spanning oncology, hematology and immunology. The deal follows the company's earlier success with Sotyktu, an…

marketbeat.com - Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)
MarketBeat

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in…

marketbeat.com - aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial
aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial
MarketBeat

aTyr Pharma NASDAQ: ATYR said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type C meeting. President and CEO Dr. Sanjay Shukla said…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Now Covered by Analysts at LADENBURG THALM/SH SH
Urogen Pharma (NASDAQ:URGN) Now Covered by Analysts at LADENBURG THALM/SH SH
MarketBeat

Equities research analysts at LADENBURG THALM/SH SH began coverage on shares of Urogen Pharma (NASDAQ:URGN - Get Free Report) in a research note issued on Monday. The brokerage set a 'buy' rating and a $43.00 price target on the stock. LADENBURG…

globenewswire.com - AC Immune SA - AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
GlobeNewswire

AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM Co-founder and CEO, Dr Andrea Pfeifer, to retire after a distinguished 23-year tenure Board Chair, Martin Zügel, MD, to be appointed interim CEO Dr Pfeifer to serve as an…

globenewswire.com - Orion Oyj - Orion Animal Health receives US FDA approval for Tessie (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs
Orion Animal Health receives US FDA approval for Tessie (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs
GlobeNewswire

Orion Animal Health receives US FDA approval for Tessie (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs Orion Corporation today announced that on 6 May 2026 the U.S. Food and Drug Administration (FDA)…

forbes.com - Frank Holmes - How AI Could Turn Cancer Detection Into The Next Big Investment Theme
How AI Could Turn Cancer Detection Into The Next Big Investment Theme
Forbes

Medical technology concept. Remote medicine. Electronic medical record. Early detection, I believe, is one of the smartest investments you can make, whether we're talking about your portfolio or your health. That's why I recently made the decision…

wsj.com - AdriĆ  Calatayud - Bayer Net Profit Surges Driven by Growth in Agricultural Division
Bayer Net Profit Surges Driven by Growth in Agricultural Division
Wall Street Journal

reported a sharply higher first-quarter net profit, aided by a gain from the sale of an antibiotics business and stronger underlying earnings at its agricultural division. The German agricultural-and-pharmaceutical group said Tuesday that net…

Receive a Daily briefing on Pharma Industry News

Get Started